⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
RNA-Based Therapeutics & Vaccines Market is projected to reach USD 2.32 Billion by 2032, growing at a CAGR of 5.50% during 2025–2032, Driven by the Rapid Expansion of mRNA Platform Applications: AnalystView Market Insights
globenewswire.com
MRNA
MRK
Merck & Co Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Incubators, ICT, Technology Initiatives, Partnerships, Investments, Acquisitions, Network Map
globenewswire.com
MRK
Understanding the Limits of Cosmetic Injectables and When to Opt for a Facelift with Dr. Nicole Schrader
accessnewswire.com
MRK
ABBV
LULU
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
prnewswire.com
MRK
EXEL
LLY
ONCY
GILD
Anti Venom Market Competitive Landscape Report 2025: Top Companies Analysis, Profiles, Strategic Developments, Mergers, Sustainability Goals, Product Innovations and Launches, Revenues
globenewswire.com
BSX
MRK
ERS Genomics launches new Early Access Express License
prnewswire.com
GSK
MRK
TMO
CTVA
DHR
CRL
Merck to Participate in the TD Cowen 46th Annual Health Care Conference
businesswire.com
MRK
Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions
businesswire.com
LLY
AMGN
AZN
MRK
Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment Market Report 2026-2032: Revenues to Grow by $750M at 8.64% CAGR
globenewswire.com
ABBV
AMGN
PFE
BMY
MRK
REGN
SNY
TAK
NVS
GSK
HRTX
Discovery Could Make Immune Checkpoint Inhibitors Safer
prnewswire.com
BMY
MRK